11-103943535-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_025208.5(PDGFD):āc.689A>Gā(p.Glu230Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000837 in 1,613,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_025208.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDGFD | NM_025208.5 | c.689A>G | p.Glu230Gly | missense_variant | 5/7 | ENST00000393158.7 | |
PDGFD | NM_033135.4 | c.671A>G | p.Glu224Gly | missense_variant | 5/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PDGFD | ENST00000393158.7 | c.689A>G | p.Glu230Gly | missense_variant | 5/7 | 1 | NM_025208.5 | P1 | |
PDGFD | ENST00000302251.9 | c.671A>G | p.Glu224Gly | missense_variant | 5/7 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000478 AC: 12AN: 250860Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135586
GnomAD4 exome AF: 0.0000862 AC: 126AN: 1461160Hom.: 0 Cov.: 31 AF XY: 0.0000784 AC XY: 57AN XY: 726884
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74332
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 03, 2022 | The c.689A>G (p.E230G) alteration is located in exon 5 (coding exon 5) of the PDGFD gene. This alteration results from a A to G substitution at nucleotide position 689, causing the glutamic acid (E) at amino acid position 230 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at